Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial

TJ Ford, B Stanley, R Good, P Rocchiccioli… - Journal of the American …, 2018 - jacc.org
Background: Patients with angina symptoms and/or signs of ischemia but no obstructive
coronary artery disease (INOCA) pose a diagnostic and therapeutic challenge. Objectives …

A randomized trial of deferred stenting versus immediate stenting to prevent no-or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)

D Carrick, KG Oldroyd, M McEntegart, C Haig… - Journal of the American …, 2014 - jacc.org
Objectives: The aim of this study was to assess whether deferred stenting might reduce no-
reflow and salvage myocardium in primary percutaneous coronary intervention (PCI) for ST …

Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention

CE Hastie, S Padmanabhan, R Slack… - European heart …, 2010 - academic.oup.com
Aims We sought to investigate the impact of body mass index (BMI) on long-term all-cause
mortality in patients following first-time elective percutaneous coronary intervention (PCI) …

Myocardial hemorrhage after acute reperfused ST-segment–elevation myocardial infarction: relation to microvascular obstruction and prognostic significance

D Carrick, C Haig, N Ahmed, M McEntegart… - Circulation …, 2016 - Am Heart Assoc
Background—The success of coronary reperfusion therapy in ST-segment–elevation
myocardial infarction (MI) is commonly limited by failure to restore microvascular perfusion …

1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

TJ Ford, B Stanley, N Sidik, R Good… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to test the hypothesis that invasive coronary function
testing at time of angiography could help stratify management of angina patients without …

Systemic microvascular dysfunction in microvascular and vasospastic angina

TJ Ford, P Rocchiccioli, R Good… - European heart …, 2018 - academic.oup.com
Aims Coronary microvascular dysfunction and/or vasospasm are potential causes of
ischaemia in patients with no obstructive coronary artery disease (INOCA). We tested the …

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR)

D Collison, M Didagelos… - European Heart …, 2021 - academic.oup.com
Aims A fractional flow reserve (FFR) value≥ 0.90 after percutaneous coronary intervention
(PCI) is associated with a reduced risk of adverse cardiovascular events. TARGET-FFR is an …

Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis

D Carrick, C Haig, S Rauhalammi, N Ahmed… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The aim of this study was to investigate the clinical significance of native T1
values in remote myocardium in survivors of acute ST-segment elevation myocardial …

Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment–elevation myocardial infarction

D Carrick, C Haig, N Ahmed, J Carberry, VT Yue May… - Circulation, 2016 - Am Heart Assoc
Background: Primary percutaneous coronary intervention is frequently successful at
restoring coronary artery blood flow in patients with acute ST-segment–elevation myocardial …

Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders

TJ Ford, E Yii, N Sidik, R Good… - Circulation …, 2019 - Am Heart Assoc
Background: Determine the prevalence and correlates of microvascular and vasospastic
angina in patients with symptoms and signs of ischemia but no obstructive coronary artery …